Triton BioSystems, Inc. (TBS) is developing non-invasive targeted therapeutics that use heat to treat cancer. The Company has leveraged its experience with magnetic nano-materials and magnetic field energy to make antibodies tumoricidal and more therapeutically selective, without the side effects of conventional therapies. TBS is developing this anticancer therapy to treat late-stage cancers such as breast, head and neck, lung, colon, ovarian, pancreatic and prostate cancers. The Company's product is referred to as the Targeted Nano-Therapeutics™ (TNT™) System.
200 Turnpike Road